| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| 37 | 55 | 8 | 12 | 3 | - | - | 115 |
| - | 3 | - | 7 | - | - | - | 10 |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| 197 | 177 | 47 | 108 | 529 |
| 56 | 38 | 2 | - | 96 |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LOP(L) | 529 | 82.1% | -2.46 | 96 | 90.6% |
| LO(L) | 115 | 17.9% | -3.52 | 10 | 9.4% |
| upstream partner | # | NT | conns LOP_LO_unclear | % In | CV |
|---|---|---|---|---|---|
| LPT114 (L) | 9 | GABA | 112 | 17.7% | 0.6 |
| T4a (L) | 22 | ACh | 101 | 16.0% | 0.8 |
| T5a (L) | 17 | ACh | 91 | 14.4% | 0.6 |
| LPT57 (R) | 1 | ACh | 50 | 7.9% | 0.0 |
| Tlp12 (L) | 7 | Glu | 46 | 7.3% | 0.6 |
| Tm2 (L) | 5 | ACh | 41 | 6.5% | 0.3 |
| Tm3 (L) | 5 | ACh | 18 | 2.8% | 0.2 |
| T4b (L) | 9 | ACh | 18 | 2.8% | 0.6 |
| TmY9b (L) | 7 | ACh | 17 | 2.7% | 0.6 |
| TmY9a (L) | 10 | ACh | 17 | 2.7% | 0.5 |
| LPi3a (L) | 4 | Glu | 16 | 2.5% | 0.6 |
| TmY20 (L) | 5 | ACh | 10 | 1.6% | 0.3 |
| T5b (L) | 8 | ACh | 10 | 1.6% | 0.3 |
| LPi2e (L) | 4 | Glu | 9 | 1.4% | 0.2 |
| Tlp13 (L) | 4 | Glu | 8 | 1.3% | 0.5 |
| TmY17 (L) | 4 | ACh | 7 | 1.1% | 0.2 |
| Tm1 (L) | 1 | ACh | 6 | 0.9% | 0.0 |
| Li30 (L) | 2 | GABA | 6 | 0.9% | 0.0 |
| Tm4 (L) | 3 | ACh | 5 | 0.8% | 0.6 |
| TmY13 (L) | 3 | ACh | 5 | 0.8% | 0.3 |
| LoVC15 (L) | 1 | GABA | 4 | 0.6% | 0.0 |
| Tm9 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| LPi3412 (L) | 3 | Glu | 4 | 0.6% | 0.4 |
| LPi4b (L) | 1 | GABA | 3 | 0.5% | 0.0 |
| LPLC2 (L) | 2 | ACh | 3 | 0.5% | 0.3 |
| T5c (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| Y11 (L) | 2 | Glu | 2 | 0.3% | 0.0 |
| LPT23 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| TmY3 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| Y3 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| LPC2 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| T5d (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Y12 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LPi2d (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LPT116 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LPLC4 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Li26 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| T2 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LPi12 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| MeLo8 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LT33 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| OA-AL2i1 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns LOP_LO_unclear | % Out | CV |
|---|---|---|---|---|---|
| Y11 (L) | 6 | Glu | 51 | 21.0% | 0.5 |
| Y13 (L) | 6 | Glu | 36 | 14.8% | 0.6 |
| LPi2e (L) | 5 | Glu | 28 | 11.5% | 0.5 |
| Tlp11 (L) | 5 | Glu | 23 | 9.5% | 0.8 |
| Y12 (L) | 6 | Glu | 23 | 9.5% | 0.9 |
| TmY20 (L) | 5 | ACh | 13 | 5.3% | 0.4 |
| Y3 (L) | 3 | ACh | 11 | 4.5% | 0.3 |
| Y14 (L) | 2 | Glu | 10 | 4.1% | 0.2 |
| TmY17 (L) | 3 | ACh | 8 | 3.3% | 0.5 |
| T5c (L) | 3 | ACh | 6 | 2.5% | 0.4 |
| LC22 (L) | 1 | ACh | 4 | 1.6% | 0.0 |
| T5a (L) | 3 | ACh | 4 | 1.6% | 0.4 |
| LPT101 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| TmY10 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| T4a (L) | 3 | ACh | 3 | 1.2% | 0.0 |
| TmY9b (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| TmY18 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| TmY14 (L) | 1 | unc | 2 | 0.8% | 0.0 |
| LLPC1 (L) | 2 | ACh | 2 | 0.8% | 0.0 |
| TmY9a (L) | 2 | ACh | 2 | 0.8% | 0.0 |
| LPLC4 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| T5b (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| T5d (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LC43 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| T4b (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| Tm4 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LPi21 (L) | 1 | GABA | 1 | 0.4% | 0.0 |